5 Written Questions
5 Multiple Choice Questions
- Nucleoside analogue, use with peginterferon. This drug blunts viral replication. HCV use.
- Shown to decrease drug resistance but not to be more effective in treatment.
- Guanosine nucleoside analog. More potent than Lamivudine and adefovir. HBV use. Can elevate LFTs.
- affect viral replication, indicated for Hep B,C,D, can give IV, IM, or SC. Flu-like side effects.
- Treat and suppress viral replication before liver damage is extensive
4 True/False Questions
Lamivudine (Epvir) → Reverse transcriptase inhibitor, HBV, patients can become resistant to this treatment. Highest in safety and patient tolerance.
Telbivudine (Tyzeka) → HBV specific, drug resistance common, can elevate cpk and cause lactic acidosis.
PEGinterferon → affect viral replication, indicated for Hep B,C,D, can give IV, IM, or SC. Flu-like side effects.
hepatitis A treatment → can use immunoglobulin if known to be within 2 weeks of exposure